Dimensional Fund Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.7M Buy
803,888
+217,570
+37% +$3.72M ﹤0.01% 2142
2025
Q1
$37.4M Buy
586,318
+275,508
+89% +$17.6M 0.01% 1618
2024
Q4
$37.8M Buy
310,810
+30,615
+11% +$3.72M 0.01% 1685
2024
Q3
$35M Buy
280,195
+24,799
+10% +$3.1M 0.01% 1711
2024
Q2
$40.4M Buy
255,396
+31,105
+14% +$4.91M 0.01% 1594
2024
Q1
$29M Buy
224,291
+90
+0% +$11.7K 0.01% 1798
2023
Q4
$21.6M Buy
224,201
+20,923
+10% +$2.02M 0.01% 1947
2023
Q3
$24.6M Buy
203,278
+20,516
+11% +$2.49M 0.01% 1807
2023
Q2
$20.9M Sell
182,762
-6,823
-4% -$781K 0.01% 1906
2023
Q1
$26.1M Sell
189,585
-3,285
-2% -$453K 0.01% 1765
2022
Q4
$25K Buy
192,870
+3,784
+2% +$490 0.01% 1750
2022
Q3
$20.9M Buy
189,086
+27,496
+17% +$3.04M 0.01% 1802
2022
Q2
$12.1M Sell
161,590
-17,704
-10% -$1.33M ﹤0.01% 2116
2022
Q1
$14M Buy
179,294
+19,660
+12% +$1.54M ﹤0.01% 2148
2021
Q4
$14.4M Sell
159,634
-7,823
-5% -$704K ﹤0.01% 2165
2021
Q3
$15.5M Buy
167,457
+5,440
+3% +$503K 0.01% 2122
2021
Q2
$12.6M Sell
162,017
-14,345
-8% -$1.12M ﹤0.01% 2254
2021
Q1
$13.2M Sell
176,362
-16,147
-8% -$1.21M ﹤0.01% 2219
2020
Q4
$32.8M Buy
192,509
+6,373
+3% +$1.09M 0.01% 1698
2020
Q3
$26.1M Buy
186,136
+3,608
+2% +$507K 0.01% 1700
2020
Q2
$29.3M Sell
182,528
-6,073
-3% -$974K 0.01% 1624
2020
Q1
$18.4M Buy
188,601
+10,369
+6% +$1.01M 0.01% 1798
2019
Q4
$23M Buy
178,232
+26,655
+18% +$3.44M 0.01% 1960
2019
Q3
$11.4M Buy
151,577
+8,475
+6% +$638K ﹤0.01% 2296
2019
Q2
$21.7M Buy
143,102
+2,500
+2% +$379K 0.01% 1997
2019
Q1
$16.8M Sell
140,602
-19,442
-12% -$2.32M 0.01% 2143
2018
Q4
$17.5M Buy
160,044
+4,602
+3% +$502K 0.01% 2055
2018
Q3
$25.1M Buy
155,442
+2,742
+2% +$443K 0.01% 1981
2018
Q2
$20.2M Buy
152,700
+40,735
+36% +$5.38M 0.01% 2101
2018
Q1
$8.3M Buy
+111,965
New +$8.3M ﹤0.01% 2445
2017
Q2
Sell
-7,079
Closed -$210K 3324
2017
Q1
$210K Buy
+7,079
New +$210K ﹤0.01% 3198